Sign in

You're signed outSign in or to get full access.

Bruno Baillavoine

Director at CEL SCICEL SCI
Board

About Bruno Baillavoine

Bruno Baillavoine, age 72, has served as an independent director of CEL-SCI (CVM) since June 2015. He chairs the Compensation Committee and sits on the Audit and Nominating & Governance Committees; the Board affirms his independence under NYSE American standards. His background spans turnaround leadership across consumer, printing, and services, with recent roles in consulting and ESG/graphite mining; education includes U.S. high school and studies at the University of Wisconsin–Eau Claire (1972–1976) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Ravenhead Ltd. (United Distillers Group)Marketing Manager; UK Business Manager1978–1982Restored market share and profit
ProntaprintGroup Corporate Planning & Group Marketing Director1982–1986Expanded to 500 locations in four years
Grand Metropolitan Plc (now Diageo)Director, Special Operations1986–1988Developed plans for troubleshooting across 20,000 retail outlets
Nutri Systems (UK) Ltd.Managing Director1988–1991UK weight-loss subsidiary leadership
BET Group plcDirector; Managing Director for manufacturing businesses1991–1995Contributed to £2.3B turnaround of FTSE 100 company
Globomass Holdings Ltd.Partner; Executive Chairman2010–2016 (Exec Chair 2012–2016)Renewable energy developer; acquired by CleanBay Inc. (he remains a significant shareholder)

External Roles

OrganizationRoleTenureNotes / Potential Interlocks
Pericles Group UK (Pericles Consulting Holdings SAS)Director; Head of Pericles Group UKSince 2017Financial services consulting; >500 institutional clients
ESG.AI (Canada)Director (initially non-executive, now executive)Since Nov 2022ESG software/services; no disclosed transactions with CEL-SCI
Gratomic Inc. (TSXV)Executive ChairJul 2023–Oct 2024; now consultantGraphite mining; no disclosed transactions with CEL-SCI
CSL Inc. (“Combat Sport Entertainment”)Advisor to Board2017–2022Retains a financial interest; no disclosed related-party transactions with CEL-SCI
CleanBay Inc.Significant shareholderSince 2016Result of Globomass acquisition; no disclosed related-party transactions with CEL-SCI

Board Governance

  • Independence: Classified as independent per NYSE American Section 803; serves on Audit, Compensation, and Nominating & Governance committees; chairs Compensation .
  • Board meetings: FY2024 Board met 5 times; all directors attended 4 meetings, and four directors attended the remaining meeting .
  • Committee attendance (FY2024): Audit Committee met 5 times; Baillavoine attended 4 of 5 (Watson 5/5, Gobbo 3/5, Young 2/5) .
  • Compensation Committee activity: Comprised of Baillavoine (Chair), Watson, Gobbo; formally met once in FY2024 .

Fixed Compensation

MetricFY2023FY2024
Annual Director Fees (Cash)$55,000 $55,000
Stock Awards (Fair Value)$0 $0
Option Awards (Fair Value)$78,330 $87,131
Total Director Compensation$133,330 $142,131

Notes:

  • Committee chair/member fees and meeting fees are not separately disclosed; director compensation appears as fees plus option awards .

Performance Compensation

Award DetailFY2023 GrantFY2024 Grant
Grant DateAug 8, 2023 Apr 19, 2024
Options Granted64,000 64,000
Exercise Price$1.36 $1.50
ExpirationAug 7, 2033 Apr 18, 2034
VestingCompany policy: pro rata at end of each of the following three years (general LTIs policy) Company policy: pro rata at end of each of the following three years (general LTIs policy)

Performance metrics tied to director compensation:

  • None disclosed; director equity grants vest time-based, with no TSR/EBITDA or operating metric conditions stated for directors. Executive-only performance options were granted in 2022 (Multikine approval trigger), not to directors .

Other Directorships & Interlocks

CompanyIs Public?RolePotential Conflict with CVM
Gratomic Inc.Yes (TSXV)Former Executive Chair; now consultantNo disclosed dealings with CEL-SCI
ESG.AINot specifiedExecutive DirectorNo disclosed dealings with CEL-SCI
CSL/Combat Sport EntertainmentPrivateFormer Advisor; retains financial interestNo disclosed related-party transactions
CleanBay Inc.PrivateSignificant shareholderNo disclosed related-party transactions

The proxy reports no compensation committee interlocks or insider participation issues in FY2024 .

Expertise & Qualifications

  • Board rationale: “Long standing relationship… diverse perspective and strong decision-making abilities” .
  • Track record: Significant turnaround and growth roles across multiple sectors; broad operating and strategic experience .

Equity Ownership

Ownership MetricValue
Total Beneficial Ownership (incl. exercisable within 60 days)422,141 shares; <1% of outstanding
Options/Warrants Exercisable by July 15, 2025416,168
Shares Outstanding (Record Date)84,124,041 (as of Mar 25, 2025)

Notes:

  • Beneficial ownership figures include securities exercisable within the stated window; breakdown of direct vs. derivative holdings is not fully detailed in director-specific tables .
  • No disclosure found of director stock ownership guidelines or hedging/pledging policies in the reviewed proxies .

Insider Trades (Form 4 references)

DateActionSharesPriceSource
Nov 18, 2020Purchase800$11.77
Jul 6, 2021Purchase1,250$8.00

Additional aggregation sources indicate Baillavoine’s director Form 4 history for CVM (CIK: 0001646989) and ownership snapshots; recent insider activity at CEL-SCI shows net insider buying over trailing periods (not specific to Baillavoine) .

Governance Assessment

  • Committee roles and independence: Strong independence footprint with chair role on Compensation and membership on all key committees; independence affirmed under NYSE American standards .
  • Engagement and attendance: Audit Committee attendance 4/5 in FY2024; Compensation Committee met just once, which may indicate limited formal oversight cadence for pay decisions (flag for small-cap governance) .
  • Pay structure and alignment: Director pay is modest cash retainer plus time-vested options; absence of performance-conditioned director awards limits direct pay-for-performance alignment, but equity exposure supports shareholder alignment in principle .
  • Ownership “skin in the game”: Beneficial ownership <1% with substantial derivative holdings exercisable within 60 days; lack of disclosed ownership guidelines and hedging/pledging policy is a governance gap for alignment assurance .
  • Conflicts/related party: Multiple external business interests (ESG.AI, Gratomic, CSL, CleanBay) with no disclosed related-party transactions with CEL-SCI; compensation committee interlocks explicitly denied for FY2024 .

RED FLAGS

  • Low Compensation Committee meeting frequency (one formal meeting in FY2024) may weaken pay oversight .
  • No disclosed director stock ownership guidelines, hedging or pledging policies; absence reduces enforceable alignment standards .
  • Board-wide attendance disclosure is aggregated; individual board meeting attendance is not detailed by director (limits assessment granularity) .

Potential Investor Signals

  • Continued equity grants to directors with long-dated expirations and three-year vesting provide alignment but lack performance gates for governance-quality signaling .
  • Proxy seeks approval for new equity plans and reverse split authorization, indicating a capital markets posture to support listing compliance and compensation flexibility; oversight quality depends on committee rigor under Baillavoine’s chair role .